Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses
New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypotheses MORRISVILLE, N.C., Oct. 20, 2026...
TraceLink Announces $1 Million Challenge to Build Agentic Business Processes
Global competition invites developers, solution partners, and business process specialists worldwide to build and demonstrate innovative AI-powered business processes using TraceLink's OPUS platform BOSTON, Oct. 20, 2026 /PRNewswire/ -- TraceLink,...
Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication
Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 20, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"),...
Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity
- Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first - in-class fixed - dose combinations. - ASC36o, a once-weekly oral amylin receptor peptide agonist, is the most advanced drug...
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today announced that it...
Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer
SUZHOU, China and PRINCETON, N.J., Oct. 19, 2026 /PRNewswire/ -- Transcenta Therapeutics (HKEX: 06628) today announced that its Board of Directors has approved the appointment of Ms. Jennie Ma as Chief Financial Officer (CFO) of the Company. In this...
Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with Cadonilimab
HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") and its partner Summit Therapeutics Inc. jointly announced an international multicenter Phase II clinical study (SMT112-216 / AK112-216 / NCT07877194). Built...
OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors
— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the United States and in China ROCKVILLE, Md. , Oct. 19, 2026 /PRNewswire/ -- OncoC4...
BUUU Group Limited Announces 10-for-1 Forward Share Split
SINGAPORE, Oct. 17, 2026 /PRNewswire/ -- BUUU Group Limited (Nasdaq: BUUU) ("BUUU" or the "Company") today announced that its board of directors has approved a ten-for-one (10-for-1) forward split of the Company's ordinary shares, to be effected by...
DKG TranXact Announces Institutional Pilot Readiness Ahead of Hong Kong and Singapore FinTech Events
Company to attend Hong Kong FinTech Week x StartmeupHK 2026 and Singapore FinTech Festival 2026, inviting financial institutions to evaluate its capital markets operations platform. TORONTO, Oct. 16, 2026 /PRNewswire/ -- DKG TranXact today announced...